The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE Cabinet approves AED 292.5 billion for 2027-2029
Dubai arrests group over fake Google reviews targeting company
UAE to train 50 young content creators on water sustainability
UAE condemns continued Houthi attacks on Riyadh airport
